Insider trading

Period: 12 months Role: Other officers × Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

2,295 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

2,295 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

2,295 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

2,295 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
2,295 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
2,295 decisions over 12 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

2,295 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
1 Dec 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold at will
$1.17M 150,000 at 7.82
89.3%
Sold half or more
1 Dec 2025
ALTSHULER KRISTI SPENCER Sr. Vice President
Sold at will
$243.02K 12,000 at 20.25
100%
Sold half or more
1 Dec 2025
Niemietz Kurt A. VP IR & Treasurer
Sold at will
$171.18K 1,500 at 114.12
61.0%
Sold half or more
1 Dec 2025
Curet Myriam EVP & Chief Medical Officer
Sold on a plan
$71.12K 125 at 568.99
100%
Sold half or more
1 Dec 2025
De Lorenzo Daniel VP, Controller & CAO
Sold on a plan
$3.63K 33 at 110.04
100%
Sold half or more
28 Nov 2025
Berman David M HEAD OF R&D
Sold on a plan
$221.34K 5,521 at 40.09
100%
Sold half or more
26 Nov 2025
Venturo Brian M Chief Strategy Officer · indirect
Sold on a plan 4×
$20.94M 281,250 at 74.44
100%
Sold half or more
26 Nov 2025
Berman David M HEAD OF R&D
Sold on a plan
$2.78M 69,404 at 40.12
100%
Sold half or more
26 Nov 2025
MANCINI CHRISTOPHER ANDREW SVP OF STORE OPERATIONS
Sold at will
$238.59K 2,355 at 101.31
98.8%
Sold half or more
26 Nov 2025
McVeety Kristen J GC and Secretary
Sold on a plan 4×
$157.70K 2,116 at 74.53
96.4%
Sold half or more
26 Nov 2025
La Lande Rashida Exec VP & General Counsel
Sold at will
$151.50K 1,604 at 94.45
100%
Sold half or more
26 Nov 2025
O'Connor John Terry General Counsel
Bought
$150.80K 2,100 at 71.81
210%
Largest buy in 3 yrs
25 Nov 2025
Boersma Travis Executive Chairman of Board · indirect
Sold on a plan 10×
$93.06M 1,678,616 at 55.44
99.4%
Sold half or more
25 Nov 2025
de la Guerroniere Marc Head of Eur & NA Market Orgs
Sold at will 2×
$9.01M 6,055 at 1,488.18
97.0%
Sold half or more
25 Nov 2025
Adelman Jonah President, ME Division
Sold at will
$2.24M 30,000 at 74.80
76.2%
Sold half or more
25 Nov 2025
Gruber Julie Chief Legal&Compliance Officer
Sold on a plan 2×
$1.68M 62,073 at 27.00
62.4%
Sold half or more
25 Nov 2025
Arregui Jesus Sr VP & President - Commercial
Sold at will 2×
$1.29M 3,831 at 337.28
59.2%
Sold half or more
25 Nov 2025
Berman David M HEAD OF R&D
Sold on a plan
$721.34K 18,020 at 40.03
100%
Sold half or more
25 Nov 2025
Huller Kelly SVP, GC, Corporate Secretary
Sold on a plan
$675.00K 7,500 at 90.00
100%
Sold half or more
25 Nov 2025
WARD TOM L. See Remarks · indirect
Bought
$499.91K 43,660 at 11.45
52.4%
+52% of stake
25 Nov 2025
Guyer William Chief Development Officer
Sold at will
$364.07K 4,500 at 80.90
85.1%
Sold half or more
25 Nov 2025
Otteni Peter V Executive Vice President
Sold at will
$300.47K 4,136 at 72.65
100%
Sold half or more
25 Nov 2025
CHRISTENSON ALICE Chief Accounting Officer
Sold at will
$229.57K 1,323 at 173.52
52.3%
Sold half or more
25 Nov 2025
Maples Mark A Vice President of Subsidiary
Sold at will
$86.90K 1,450 at 59.93
100%
Sold half or more
25 Nov 2025
Zawitz David Chief Operating Officer
Bought
$42.43K 10,000 at 4.24
90.9%
First buy on file
25 Nov 2025
Kang Daniel Chief Strategy Officer
Bought
$28.98K 4,200 at 6.90
141%
First buy on file
25 Nov 2025
Moreadith Randall Chief Scientific Officer
Sold on a plan
$23.26K 5,965 at 3.90
50.0%
Sold half or more
25 Nov 2025
DIMELLA ROBERT A Portfolio Manager
Sold at will
$10.67 1 at 14.92
100%
Sold half or more
25 Nov 2025
DIMELLA ROBERT A Portfolio Manager
Sold at will
$1.34 0 at 14.50
100%
Sold half or more
25 Nov 2025
DIMELLA ROBERT A Portfolio Manager
Sold at will
$0.16 0 at 12.73
100%
Sold half or more
24 Nov 2025
Boersma Travis Executive Chairman of Board · indirect
Sold on a plan 6×
$43.87M 821,384 at 53.41
55.5%
Sold half or more
24 Nov 2025
Shikin Vasily Chief Technology Officer · indirect
Sold on a plan 111×
$28.70M 52,500 at 546.76
59.4%
Sold half or more
24 Nov 2025
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 3×
$10.66M 22,500 at 473.66
100%
Sold half or more
24 Nov 2025
Zatlyn Michelle President and Board Co-Chair · indirect
Sold on a plan 3×
$4.85M 25,641 at 189.07
51.1%
Sold half or more
24 Nov 2025
RICHARDS GEOFFREY See Remarks · indirect
Sold at will 2×
$4.08M 62,525 at 65.17
61.2%
Sold half or more
24 Nov 2025
Brock Lawrence J Chief People Officer
Sold on a plan 13×
$1.48M 5,902 at 250.58
92.2%
Sold half or more
24 Nov 2025
Kurtzman Diane EVP & Chief HR Officer
Sold at will
$1.39M 4,805 at 290.00
55.7%
Sold half or more
24 Nov 2025
Liang Stephen Chief Technology Officer & EVP
Sold at will
$937.81K 5,501 at 170.48
57.6%
Sold half or more
24 Nov 2025
Jones Jennifer N. Chief Accounting Officer
Sold on a plan
$436.90K 1,787 at 244.49
100%
Sold half or more
24 Nov 2025
Regan-Levine Evan Chief Strategy Officer
Sold at will 2×
$80.29K 4,485 at 17.90
100%
Sold half or more
24 Nov 2025
Moran Edwin B. President
Bought
$13.65K 500 at 27.29
100%
+100% of stake
24 Nov 2025
Berman David M HEAD OF R&D
Sold on a plan
$4.00K 100 at 40.00
100%
Sold half or more
24 Nov 2025
Moreadith Randall Chief Scientific Officer
Sold on a plan
$2.11K 535 at 3.94
100%
Sold half or more
21 Nov 2025
Cohen Stephen Andrew See Remarks
Sold at will 3×
$6.12M 39,136 at 156.25
98.5%
Sold half or more
21 Nov 2025
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold on a plan
$5.22M 308,477 at 16.91
51.0%
Sold half or more
21 Nov 2025
Zatlyn Michelle President and Board Co-Chair · indirect
Sold on a plan 4×
$4.82M 25,641 at 188.13
51.1%
Sold half or more
21 Nov 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will 4×
$2.13M 47,376 at 45.04
51.4%
Sold half or more
21 Nov 2025
GUSTAVSON JEFF B Vice President
Sold at will
$1.40M 9,325 at 150.27
84.8%
Sold half or more
21 Nov 2025
Keller Gerry Head of Process Analytics
Sold at will
$334.78K 236 at 1,418.58
59.7%
Sold half or more
21 Nov 2025
Grech Patricia Y SVP & CAO · indirect
Sold on a plan
$82.57K 513 at 160.95
71.6%
Sold half or more
Showing 2,001–2,050 of 2,295. ← Newer Page 41 of 46 Older →